Duke engineers develop AI platform to target undruggable disease proteins

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing proteins.

EC grants expanded indication approval for Merck’s Ebola vaccine

Ervebois is indicated for active immunisation of the paediatric population against Zaire ebolavirus-caused Ebola virus disease. Credit: Novikov Aleksey / Shutterstock.com. The European Commission (EC)

September 8, 2023

Mindbio Completes Final Post Treatment Milestone in Phase 2A Microdosing Depression Clinical Trial | Psychedelic Invest

MindBio Therapeutics Corp. reported that the final milestone in the Company’s Phase 2A Microdosing Depression Clinical Trial, the 6-month post treatment milestone measuring the “severity

October 22, 2024

Letters: This Fourth of July, remember Juneteenth – the day all Americans were finally free – The Cannabist

This Fourth, remember Juneteenth As America celebrated Juneteenth, let us reflect on a decision that did more to shape Republican values than any other decision

July 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.